A new trading day began on Tuesday, with Cogent Biosciences Inc (NASDAQ: COGT) stock price up 3.73% from the previous day of trading, before settling in for the closing price of $11.79. COGT’s price has ranged from $3.72 to $12.97 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 10.02% over the past five years. Meanwhile, its annual earnings per share averaged 12.52%. With a float of $112.56 million, this company’s outstanding shares have now reached $113.93 million.
Cogent Biosciences Inc (COGT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 19.43%, while institutional ownership is 87.34%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.64 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.98% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Here are Cogent Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.42, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.82 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Cogent Biosciences Inc (NASDAQ: COGT) saw its 5-day average volume 0.96 million, a negative change from its year-to-date volume of 1.95 million. As of the previous 9 days, the stock’s Stochastic %D was 63.76%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 92.00%, which indicates a significant increase from 88.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.53 in the past 14 days, which was higher than the 0.52 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.46, while its 200-day Moving Average is $8.03. Nevertheless, the first resistance level for the watch stands at $12.45 in the near term. At $12.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.00. If the price goes on to break the first support level at $11.90, it is likely to go to the next support level at $11.58. The third support level lies at $11.35 if the price breaches the second support level.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
With a market capitalization of 1.71 billion, the company has a total of 113,856K Shares Outstanding. Currently, annual sales are 0 K while annual income is -255,860 K. The company’s previous quarter sales were 0 K while its latest quarter income was -73,530 K.
